NCT07246057 Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships
| NCT ID | NCT07246057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 92 participants |
| Start Date | 2026-03-26 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 92 participants in total. It began in 2026-03-26 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to learn if STEP-UP (Streamlining Telehealth for Expanded PrEP Utilization through community Partnerships) works to expand access to PrEP for people who could benefit from HIV prevention tools. STEP-UP is an innovative model for PrEP delivery that positions community-based organizations (CBOs) as hubs for PrEP access. STEP-UP builds on the established trust, community expertise, and comprehensive services of CBOs serving individuals who could benefit from HIV prevention tools, integrating telehealth PrEP delivery into their existing infrastructure through partnership with a local telehealth PrEP program. By enabling CBOs to offer telePrEP navigation within their array of health and social services, STEP-UP creates accessible, comprehensive care centers that address barriers to PrEP access faced by individuals who could benefit from HIV prevention tools. The main questions it aims to answer are: 1. Is STEP-UP acceptable and feasible to implement in community settings? 2. Does STEP-UP increase PrEP prescription rates compared to the existing direct-to-consumer telehealth model? Researchers will compare people who receive telehealth PrEP services through STEP-UP at community-based organizations to those who access telehealth PrEP through the existing direct-to-consumer telehealth model. Some participants will: 1. Complete surveys about their experiences with the program 2. Participate in an interview to share their perspectives and feedback about the program.
Eligibility Criteria
Inclusion - Client Interviews: 1. At least 18 years of age or older 2. Have received services or participated in programming at a partner CBO in the past 12 months 3. Currently live in the Philadelphia metropolitan area 4. Able to provide informed consent Staff Interviews: 1. At least 18 years of age or older 2. Currently employed at Philadelphia telePrEP Program or a partner CBO 3. Serve in a client-facing role (e.g., outreach specialists) or leadership position (e.g., program coordinators) at one of the aforementioned organizations 4. Have been in their current role for at least 6 months 5. Able to provide informed consent Client Surveys: 1. At least 16 years of age or older 2. Have engaged with a Community TelePrEP Navigator through a partner site CBO to schedule a telehealth appointment with a PrEP provider 3. Currently live in the Philadelphia metropolitan area 4. Able to provide informed consent Exclusion- 1. Under 16 years of age (clients surveys) or under 18 years of age (staff interviews or client interviews) 2. Do not currently live in the Philadelphia metropolitan area 3. Unable to provide informed consent due to cognitive impairment or other factors 4. Individuals who pose a safety risk to research staff or other participants 5. Clients currently living with HIV
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07246057 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07246057 currently recruiting?
Yes, NCT07246057 is actively recruiting participants. Contact the research team at stepdo@nursing.upenn.edu for enrollment information.
Where is the NCT07246057 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT07246057 clinical trial?
NCT07246057 is sponsored by University of Pennsylvania. The trial plans to enroll 92 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.